Results 121 to 130 of about 21,748 (299)
Amino acids, glucose metabolism and clinical relevance for phenylketonuria management [PDF]
, 2015 It is general knowledge that glycaemia is affected by digested nutrients.Amino acids intake appears to be an important regulator in this regard. Many questions need to be answered, such as the real mediators of this responseand the mechanisms underlying ...
Borges, Nuno, Pena, MJ, Rocha, JC
core
Role of Fibre in Nutritional Management of Pancreatic Diseases [PDF]
, 2019 The role of fibre intake in the management of patients with pancreatic disease is still controversial. In acute pancreatitis, a prebiotic enriched diet is associated with low rates of pancreatic necrosis infection, hospital stay, systemic inflammatory ...
Badiali, Danilo +7 more
core +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims Despite the established efficacy of tirzepatide in randomised controlled trials, real‐world effectiveness data in Japanese patients remain limited. This study evaluated the real‐world effectiveness and safety of tirzepatide in Japanese patients with type 2 diabetes over 52 weeks.
Yusuke Minakata +3 more
wiley +1 more source
The effect of sweeteners on carbohydrate metabolism, metabolic parameters and intestinal microbiota
Ожирение и метаболизмThe prevalence of obesity and type 2 diabetes continues to grow, which determines the need to develop new methods of prevention in order to reduce the population risks of developing these diseases.
N. V. Silina +3 more
doaj +1 more source
Incretins and bone: friend or foe? [PDF]
, 2015 To adapt to its various functions, the bone tissue is remodeled permanently and is under the influence of hormonal, local, mechanical and nervous signals.
G. Mabilleau
core +4 more sources
Endogenous GIP signaling is indispensable for DPP‐4 inhibitor‐mediated metabolic control in mice
Journal of Diabetes Investigation, EarlyView.This study reveals that the metabolic benefits of DPP‐4 inhibitors, including improved glucose tolerance and reduced body weight, are completely abolished in GIP receptor‐deficient mice. These findings establish that endogenous GIP signaling, rather than GLP‐1, is the indispensable key player for the efficacy of this drug class.
Saki Kubota‐Okamoto +17 more
wiley +1 more source
Ожирение и метаболизмBACKGROUND: Obesity is a pathology that highly contributes to the development of type 2 diabetes mellitus and cardiovascular diseases. Meanwhile, different obesity phenotypes have varying levels of risk, and the indication of early predictors that can ...
G. A. Matveev +3 more
doaj +1 more source
The cardiovascular safety of incretin-based therapies: a review of the evidence [PDF]
, 2013 Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in people with diabetes and therefore managing cardiovascular (CV) risk is a critical component of diabetes care. As incretin-based therapies are effective recent additions to the
Petrie, J.R.
core +2 more sources
Journal of Internal Medicine, EarlyView.Abstract Increased urinary albumin excretion is a strong predictor for cardiovascular events in persons with and without decreased glomerular filtration rate and can be assessed with the urinary albumin‐to‐creatinine ratio (UACR), which is a selective, sensitive, and convenient method for patients.
Holly J. Kramer, George L. Bakris
wiley +1 more source
Incretin-based therapy for the treatment of bone fragility in diabetes mellitus [PDF]
, 2018 Bone fractures are common comorbidities of type 2 diabetes mellitus (T2DM). Bone fracture incidence seems to develop due to increased risk of falls, poor bone quality and/or anti-diabetic medications.
B. Bouvard +3 more
core +2 more sources